Table 4.
Study population (N = 1,814): demographic and clinical characteristics
| Characteristic | N | Valid % |
|---|---|---|
| Gender | ||
| Female | 760 | 41.9 |
| Race | ||
| Caucasian | 872 | 48.3 |
| African American | 139 | 7.7 |
| Native American/Canadian | 158 | 8.7 |
| Other including mixed race | 637 | 36.6 |
| Unknown race | 8 | -- |
| Age at diagnosis (years) | ||
| 0–2.9 | 226 | 12.5 |
| 3–5.9 | 420 | 23.2 |
| 6–7.9 | 297 | 16.4 |
| 8–12.9 | 508 | 28.0 |
| 13–18.9 | 281 | 15.4 |
| 19–51 | 82 | 4.5 |
| Mean (SD) min-max | 8.9 (6.1) 0.2–50.9 | |
| FASD diagnoses* | ||
| FAS (AB) | 82 | 4.5 |
| PFAS (C) | 123 | 6.8 |
| SE/AE (EF) | 504 | 27.8 |
| ND/AE (GH) | 943 | 52.0 |
| SP/AE (I) | 40 | 2.2 |
| No abnormalities/AE (J) | 122 | 6.7 |
| Reported prenatal alcohol exposure | ||
| First trimester only | 224 | 15.7 |
| First and second trimesters only | 183 | 12.9 |
| All three trimesters | 970 | 68.2 |
| Other trimester combinations | 46 | 3.2 |
| 1–3 days per week | 401 | 41.5 |
| 4–6 days per week | 192 | 19.9 |
| Daily | 373 | 38.6 |
*
FASD 4-Digit Code nomenclature: FAS, fetal alcohol syndrome; PFAS, partial FAS; SE/AE, static encephalopathy/alcohol-exposed; ND/AE: neurodevelopmental disorder/alcohol-exposed; SP/AE: sentinel physical findings/alcohol-exposed. Sentinel physical findings include growth deficiency and/or FAS facial features at the Rank 3 or 4 level